Skip to main content

. 1995 Dec 2;311(7018):1486–1487. doi: 10.1136/bmj.311.7018.1486

Cardiac arrest due to severe hyperkalaemia in patient taking nabumetone and low salt diet.

B Pal ¹, A Hutchinson ¹, A Bhattacharya ¹, A Ralston ¹

PMCID: PMC2543725 PMID: 8520342

1487

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Boers M. Renal disorders in rheumatoid arthritis. Semin Arthritis Rheum. 1990 Aug;20(1):57–68. doi: 10.1016/0049-0172(90)90095-w. [DOI] [PubMed] [Google Scholar]
Hyneck M. L. An overview of the clinical pharmacokinetics of nabumetone. J Rheumatol Suppl. 1992 Nov;36:20–24. [PubMed] [Google Scholar]
Pal B., Hossain M. A. Non-steroidal anti-inflammatory drugs and adverse renal effects. Ann Rheum Dis. 1985 Mar;44(3):212–213. doi: 10.1136/ard.44.3.212-b. [DOI] [PMC free article] [PubMed] [Google Scholar]
Reeves W. B., Foley R. J., Weinman E. J. Renal dysfunction from nonsteroidal anti-inflammatory drugs. Arch Intern Med. 1984 Oct;144(10):1943–1944. doi: 10.1001/archinte.144.10.1943. [DOI] [PubMed] [Google Scholar]
Segasothy M., Chin G. L., Sia K. K., Zulfiqar A., Samad S. A. Chronic nephrotoxicity of anti-inflammatory drugs used in the treatment of arthritis. Br J Rheumatol. 1995 Feb;34(2):162–165. doi: 10.1093/rheumatology/34.2.162. [DOI] [PubMed] [Google Scholar]
Stillman M. T., Napier J., Blackshear J. L. Adverse effects of nonsteroidal anti-inflammatory drugs on the kidney. Med Clin North Am. 1984 Mar;68(2):371–385. doi: 10.1016/s0025-7125(16)31136-1. [DOI] [PubMed] [Google Scholar]
Swales J. D. Salt substitutes and potassium intake. BMJ. 1991 Nov 2;303(6810):1084–1085. doi: 10.1136/bmj.303.6810.1084. [DOI] [PMC free article] [PubMed] [Google Scholar]
Whelton A., Hamilton C. W. Nonsteroidal anti-inflammatory drugs: effects on kidney function. J Clin Pharmacol. 1991 Jul;31(7):588–598. doi: 10.1002/j.1552-4604.1991.tb03743.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES